AR013538A1 - Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos - Google Patents

Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos

Info

Publication number
AR013538A1
AR013538A1 ARP980104917A ARP980104917A AR013538A1 AR 013538 A1 AR013538 A1 AR 013538A1 AR P980104917 A ARP980104917 A AR P980104917A AR P980104917 A ARP980104917 A AR P980104917A AR 013538 A1 AR013538 A1 AR 013538A1
Authority
AR
Argentina
Prior art keywords
compounds
preparing
methods
drugs containing
mythogenes
Prior art date
Application number
ARP980104917A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of AR013538A1 publication Critical patent/AR013538A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se refiere a compuestos de formula (I) donde: R1=alquilo, alquenilo o alquinilo con 6 a 24 átomos de carbono; n= 0-12; X= oxígeno o NH; ylas sales fisiologicamente tolerables, ésteres, formas opticamente activas, racematos y susderivados que pueden ser metabolizados in vivo para rendircompuestos de formula general (I), métodos para prepararlos, y drogas que contienen dichos compuestos, para el tratamiento de desordenes metabolicos delos huesos.
ARP980104917A 1997-10-02 1998-10-02 Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos AR013538A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97117124A EP0906759A1 (de) 1997-10-02 1997-10-02 Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AR013538A1 true AR013538A1 (es) 2000-12-27

Family

ID=8227430

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104917A AR013538A1 (es) 1997-10-02 1998-10-02 Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos

Country Status (16)

Country Link
US (1) US6197759B1 (es)
EP (2) EP0906759A1 (es)
JP (2) JP2001518511A (es)
KR (1) KR100392207B1 (es)
CN (1) CN1191070C (es)
AR (1) AR013538A1 (es)
AT (1) ATE232103T1 (es)
AU (1) AU738479B2 (es)
BR (1) BR9813020A (es)
CA (1) CA2304821C (es)
DE (1) DE69811253T2 (es)
DK (1) DK1019062T3 (es)
ES (1) ES2191350T3 (es)
TR (1) TR200000875T2 (es)
WO (1) WO1999017781A1 (es)
ZA (1) ZA988952B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452178A1 (en) * 2001-11-12 2004-09-01 Ono Pharmaceutical Co., Ltd. Persistent filmy preparation for topical administration containing prostaglandin derivative
AU2003256300A1 (en) 2002-06-24 2004-01-06 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Complexed-acidic-phospholipid-collagen composites for bone induction
KR100789323B1 (ko) * 2005-07-20 2007-12-28 주식회사 엔지켐 글리세롤 유도체의 위치 선택적 제조방법 및 그 중간체
US20100266691A1 (en) * 2009-04-15 2010-10-21 Battelle Memorial Institute Agents and Methods to Stimulate Bone Healing
CN113842504B (zh) * 2021-09-22 2022-12-09 苏州大学附属第二医院 一种用于骨再生的多功能电纺支架的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
PL151315B1 (pl) * 1987-04-17 1990-08-31 Sposób wytwarzania nowych związków powierzchniowo czynnych
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5238965A (en) * 1991-05-31 1993-08-24 The Procter & Gamble Company Methods of using lysophosphatidic acids for regulating skin wrinkles
ATE142460T1 (de) 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis
WO1993020859A1 (en) 1992-04-20 1993-10-28 Board Of Regents Of The University Of Washington Sustained release compositions for delivery of growth factors
CA2093836A1 (en) 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions
CA2119090A1 (en) 1993-03-26 1994-09-27 Wayne R. Gombotz Compositions for controlled release of biologically active tgf-.beta.
ATE169924T1 (de) * 1993-05-18 1998-09-15 Takeda Chemical Industries Ltd Benzopyran-derivate und ihre verwendung
ES2065855B1 (es) * 1993-05-31 1995-09-01 Menarini Lab Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DE19544635A1 (de) 1995-11-30 1997-06-05 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
DK1019062T3 (da) 2003-05-26
ES2191350T3 (es) 2003-09-01
EP0906759A1 (de) 1999-04-07
EP1019062B1 (en) 2003-02-05
TR200000875T2 (tr) 2000-11-21
CA2304821C (en) 2005-08-02
ATE232103T1 (de) 2003-02-15
DE69811253D1 (de) 2003-03-13
AU738479B2 (en) 2001-09-20
AU1148399A (en) 1999-04-27
CN1191070C (zh) 2005-03-02
DE69811253T2 (de) 2003-12-04
EP1019062A1 (en) 2000-07-19
CN1271289A (zh) 2000-10-25
JP2004217667A (ja) 2004-08-05
KR20010030822A (ko) 2001-04-16
BR9813020A (pt) 2000-08-15
KR100392207B1 (ko) 2003-07-23
US6197759B1 (en) 2001-03-06
CA2304821A1 (en) 1999-04-15
WO1999017781A1 (en) 1999-04-15
JP2001518511A (ja) 2001-10-16
ZA988952B (en) 2000-04-03

Similar Documents

Publication Publication Date Title
SE0104334D0 (sv) Therapeutic agents
DE3779500D1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
ES2190674T3 (es) Uso de n-alquil derivados de cadena larga de desoxinojirimicina para la fabricacion de un medicamento para el tratamiento de enfermedades de acumulacion de glucolipidos.
BR0016882A (pt) ésteres derivados de (rr,ss)-3-(2-dimetilaminometil-1-hidroxicicloexil)fenil 2-hidroxibenzoato
MY102866A (en) Amide derivatives.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
GT200000183A (es) Aminoacidos biciclicos como agentes farmaceuticos.
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
AR010328A1 (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, procedimiento para su preparacion, medicamentos y su utilizacion para la fabricacion demedicamentos
ES2164465T3 (es) Uso de aminometil-cromanos sustituidos para evitar la degeneracion neuronal y para estimular la regeneracion neuronal.
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
AR019859A1 (es) Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento
PT90308A (pt) Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
AR013538A1 (es) Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos
DE69227583T2 (de) Arylmorpholine, herstellung und verwendung
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
ES2125354T3 (es) Composicion a base de tandospirona o de sus analogos.
ES2171553T3 (es) Derivados de quinoxalina utiles en terapia.
SE0104333D0 (sv) Therapeutic agents
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TW200724138A (en) Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use

Legal Events

Date Code Title Description
FB Suspension of granting procedure